| scholarly article | Q13442814 |
| P2093 | author name string | Liang Chen | |
| Haiyan Wang | |||
| Meng Yang | |||
| Mingjian Ding | |||
| Wenhua Yang | |||
| Chenhao Li | |||
| Dongliang Shi | |||
| P2860 | cites work | MicroRNA-7 inhibits proliferation, migration and invasion of thyroid papillary cancer cells via targeting CKS2. | Q51502316 |
| Long non-coding RNA CCAL promotes papillary thyroid cancer progression by activation of NOTCH1 pathway. | Q52689435 | ||
| Up-regulation of microRNA in bladder tumor tissue is not common. | Q53309914 | ||
| Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer. | Q54146288 | ||
| Impact of molecular alterations of BRAF in the pathogenesis of thyroid cancer. | Q54227207 | ||
| Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue | Q79358419 | ||
| Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma | Q88514196 | ||
| MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression | Q89038430 | ||
| MiR-26a inhibits thyroid cancer cell proliferation by targeting ARPP19 | Q90405854 | ||
| BRAF V600E Gene Mutation Is Associated With Bilateral Malignancy of Papillary Thyroid Cancer | Q91464229 | ||
| The role of miR-26 in tumors and normal tissues (Review) | Q24629056 | ||
| The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| Wnt-5a has tumor suppressor activity in thyroid carcinoma | Q28237192 | ||
| MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin | Q28263940 | ||
| MicroRNA in cancer prognosis | Q28304380 | ||
| Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context | Q28510950 | ||
| E2F, HSF2, and miR-26 in thyroid carcinoma: bioinformatic analysis of RNA-sequencing data | Q31059496 | ||
| Comparative study of ROR2 and WNT5a expression in squamous/adenosquamous carcinoma and adenocarcinoma of the gallbladder | Q33572690 | ||
| miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro | Q33579391 | ||
| Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer | Q33991698 | ||
| Genetic variation in microRNA networks: the implications for cancer research | Q34177121 | ||
| Update on thyroid cancer treatment | Q34310219 | ||
| Conditional survival in patients with thyroid cancer | Q34711239 | ||
| Retracted: miR-26a and its Target CKS2 Modulate Cell Growth and Tumorigenesis of Papillary Thyroid Carcinoma | Q34825705 | ||
| Association between microRNA polymorphisms and papillary thyroid cancer susceptibility | Q35883006 | ||
| Wnt-5a gene expression in malignant human neuroblasts | Q36144733 | ||
| Current Diagnosis and Management of Thyroid Nodules | Q36191288 | ||
| Analysis of patients with anaplastic thyroid cancer expected to have curative surgery | Q36207714 | ||
| MicroRNA function: multiple mechanisms for a tiny RNA? | Q36325449 | ||
| microRNA-141 inhibits thyroid cancer cell growth and metastasis by targeting insulin receptor substrate 2. | Q36878582 | ||
| Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis | Q37035285 | ||
| MicroRNA-based therapeutics for cancer | Q37432033 | ||
| The opposing roles of Wnt-5a in cancer | Q37551599 | ||
| Cell/tissue-tropic functions of Wnt5a signaling in normal and cancer cells | Q37723044 | ||
| The planar cell polarity pathway in vertebrate development | Q37838366 | ||
| Wnt/Ca2+ signaling pathway: a brief overview | Q37929439 | ||
| High basal levels of functional toll-like receptor 3 (TLR3) and noncanonical Wnt5a are expressed in papillary thyroid cancer and are coordinately decreased by phenylmethimazole together with cell proliferation and migration | Q38505791 | ||
| MicroRNA Expression and Association with Clinicopathologic Features in Papillary Thyroid Cancer: A Systematic Review. | Q38594533 | ||
| miR-26a and miR-26b inhibit esophageal squamous cancer cell proliferation through suppression of c-MYC pathway | Q38704640 | ||
| MicroRNA-154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a | Q38808710 | ||
| DNA methylation of MAPK signal-inhibiting genes in papillary thyroid carcinoma | Q39063827 | ||
| MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway | Q39063949 | ||
| Correlation of Wnt5a expression with histopathological grade/stage in urothelial carcinoma of the bladder | Q39110071 | ||
| Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis | Q40361017 | ||
| Features Predictive of Distant Metastasis in Papillary Thyroid Microcarcinomas | Q41127617 | ||
| MiR-221 Exacerbate Cell Proliferation and Invasion by Targeting TIMP3 in Papillary Thyroid Carcinoma | Q42067988 | ||
| Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling | Q46686046 | ||
| Higher expression level of tyrosine kinase-like orphan receptor 2 and Wnt member 5a in papillary thyroid carcinoma is associated with poor prognosis | Q47162063 | ||
| Special types of thyroid carcinoma. | Q48120106 | ||
| MicroRNA-1253 suppresses cell proliferation and invasion of non-small-cell lung carcinoma by targeting WNT5A. | Q50130183 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | papillary thyroid cancer | Q2292945 |
| P304 | page(s) | 6605-6616 | |
| P577 | publication date | 2019-08-16 | |
| P1433 | published in | OncoTargets and Therapy | Q7092081 |
| P1476 | title | MicroRNA-26a-5p inhibits proliferation, invasion and metastasis by repressing the expression of Wnt5a in papillary thyroid carcinoma | |
| P478 | volume | 12 |
| Q98623219 | ARNTL2 promotes pancreatic ductal adenocarcinoma progression through TGF/BETA pathway and is regulated by miR-26a-5p |
| Q90435848 | Clinical significance of miR-19b-3p in patients with sepsis and its regulatory role in the LPS-induced inflammatory response |
| Q92447657 | Dissimilar Appearances Are Deceptive-Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma |
| Q90698087 | Effects of CDK6 regulated by miR-298 on proliferation and apoptosis of thyroid cancer cells |
Search more.